Two Sigma Advisers’s Autolus Therapeutics AUTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-164,700
| Closed | -$255K | – | 2320 |
|
|
2025
Q1 | $255K | Sell |
164,700
-168,700
| -51% | -$261K | ﹤0.01% | 2050 |
|
|
2024
Q4 | $783K | Buy |
333,400
+15,400
| +5% | +$36.2K | ﹤0.01% | 1571 |
|
|
2024
Q3 | $1.15M | Buy |
318,000
+61,300
| +24% | +$223K | ﹤0.01% | 1348 |
|
|
2024
Q2 | $893K | Buy |
256,700
+225,600
| +725% | +$785K | ﹤0.01% | 1604 |
|
|
2024
Q1 | $198K | Buy |
31,100
+1,500
| +5% | +$9.57K | ﹤0.01% | 2216 |
|
|
2023
Q4 | $191K | Buy |
29,600
+4,500
| +18% | +$29K | ﹤0.01% | 2244 |
|
|
2023
Q3 | $58.5K | Sell |
25,100
-1,300
| -5% | -$3.03K | ﹤0.01% | 2263 |
|
|
2023
Q2 | $62.8K | Buy |
26,400
+12,700
| +93% | +$30.2K | ﹤0.01% | 2252 |
|
|
2023
Q1 | $25.2K | Buy |
+13,700
| New | +$25.2K | ﹤0.01% | 2507 |
|
|
2021
Q2 | – | Sell |
-13,900
| Closed | -$80K | – | 2444 |
|
|
2021
Q1 | $80K | Buy |
+13,900
| New | +$80K | ﹤0.01% | 2463 |
|